Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

US Spirulina Market

ID: MRFR/FnB/13262-HCR
128 Pages
Snehal Singh
Last Updated: April 06, 2026

US Spirulina Market Size, Share, Industry Trend & Analysis Research Report: By Type (Arthrospira platensis, Arthrospira maxima) andBy Application (Food & Beverage, Dietary Supplements, Cosmetics and Personal Care)- Forecast to 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

US Spirulina Market Infographic
Purchase Options
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Medical Device, BY Type (USD Million)
  49.     4.1.1 Arthrospira platensis
  50.     4.1.2 Arthrospira maxima
  51.   4.2 Medical Device, BY Application (USD Million)
  52.     4.2.1 Food & Beverage
  53.     4.2.2 Dietary Supplements
  54.     4.2.3 Cosmetics and Personal Care
  55. 5 SECTION V: COMPETITIVE ANALYSIS
  56.   5.1 Competitive Landscape
  57.     5.1.1 Overview
  58.     5.1.2 Competitive Analysis
  59.     5.1.3 Market share Analysis
  60.     5.1.4 Major Growth Strategy in the Medical Device
  61.     5.1.5 Competitive Benchmarking
  62.     5.1.6 Leading Players in Terms of Number of Developments in the Medical Device
  63.     5.1.7 Key developments and growth strategies
  64.       5.1.7.1 New Product Launch/Service Deployment
  65.       5.1.7.2 Merger & Acquisitions
  66.       5.1.7.3 Joint Ventures
  67.     5.1.8 Major Players Financial Matrix
  68.       5.1.8.1 Sales and Operating Income
  69.       5.1.8.2 Major Players R&D Expenditure. 2023
  70.   5.2 Company Profiles
  71.     5.2.1 DIC Corporation (JP)
  72.       5.2.1.1 Financial Overview
  73.       5.2.1.2 Products Offered
  74.       5.2.1.3 Key Developments
  75.       5.2.1.4 SWOT Analysis
  76.       5.2.1.5 Key Strategies
  77.     5.2.2 Cyanotech Corporation (US)
  78.       5.2.2.1 Financial Overview
  79.       5.2.2.2 Products Offered
  80.       5.2.2.3 Key Developments
  81.       5.2.2.4 SWOT Analysis
  82.       5.2.2.5 Key Strategies
  83.     5.2.3 Algatechnologies Ltd. (IL)
  84.       5.2.3.1 Financial Overview
  85.       5.2.3.2 Products Offered
  86.       5.2.3.3 Key Developments
  87.       5.2.3.4 SWOT Analysis
  88.       5.2.3.5 Key Strategies
  89.     5.2.4 Earthrise Nutritionals LLC (US)
  90.       5.2.4.1 Financial Overview
  91.       5.2.4.2 Products Offered
  92.       5.2.4.3 Key Developments
  93.       5.2.4.4 SWOT Analysis
  94.       5.2.4.5 Key Strategies
  95.     5.2.5 Nutrex Hawaii Inc. (US)
  96.       5.2.5.1 Financial Overview
  97.       5.2.5.2 Products Offered
  98.       5.2.5.3 Key Developments
  99.       5.2.5.4 SWOT Analysis
  100.       5.2.5.5 Key Strategies
  101.     5.2.6 Spirulina Pacifica (US)
  102.       5.2.6.1 Financial Overview
  103.       5.2.6.2 Products Offered
  104.       5.2.6.3 Key Developments
  105.       5.2.6.4 SWOT Analysis
  106.       5.2.6.5 Key Strategies
  107.     5.2.7 Parry Nutraceuticals (IN)
  108.       5.2.7.1 Financial Overview
  109.       5.2.7.2 Products Offered
  110.       5.2.7.3 Key Developments
  111.       5.2.7.4 SWOT Analysis
  112.       5.2.7.5 Key Strategies
  113.     5.2.8 Greens Organic (AU)
  114.       5.2.8.1 Financial Overview
  115.       5.2.8.2 Products Offered
  116.       5.2.8.3 Key Developments
  117.       5.2.8.4 SWOT Analysis
  118.       5.2.8.5 Key Strategies
  119.   5.3 Appendix
  120.     5.3.1 References
  121.     5.3.2 Related Reports
  122. 6 LIST OF FIGURES
  123.   6.1 MARKET SYNOPSIS
  124.   6.2 US MARKET ANALYSIS BY TYPE
  125.   6.3 US MARKET ANALYSIS BY APPLICATION
  126.   6.4 KEY BUYING CRITERIA OF MEDICAL DEVICE
  127.   6.5 RESEARCH PROCESS OF MRFR
  128.   6.6 DRO ANALYSIS OF MEDICAL DEVICE
  129.   6.7 DRIVERS IMPACT ANALYSIS: MEDICAL DEVICE
  130.   6.8 RESTRAINTS IMPACT ANALYSIS: MEDICAL DEVICE
  131.   6.9 SUPPLY / VALUE CHAIN: MEDICAL DEVICE
  132.   6.10 MEDICAL DEVICE, BY TYPE, 2024 (% SHARE)
  133.   6.11 MEDICAL DEVICE, BY TYPE, 2024 TO 2035 (USD Million)
  134.   6.12 MEDICAL DEVICE, BY APPLICATION, 2024 (% SHARE)
  135.   6.13 MEDICAL DEVICE, BY APPLICATION, 2024 TO 2035 (USD Million)
  136.   6.14 BENCHMARKING OF MAJOR COMPETITORS
  137. 7 LIST OF TABLES
  138.   7.1 LIST OF ASSUMPTIONS
  139.     7.1.1
  140.   7.2 US MARKET SIZE ESTIMATES; FORECAST
  141.     7.2.1 BY TYPE, 2025-2035 (USD Million)
  142.     7.2.2 BY APPLICATION, 2025-2035 (USD Million)
  143.   7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  144.     7.3.1
  145.   7.4 ACQUISITION/PARTNERSHIP
  146.     7.4.1

US Medical Device Market Segmentation

Medical Device By Type (USD Million, 2025-2035)

  • Arthrospira platensis
  • Arthrospira maxima

Medical Device By Application (USD Million, 2025-2035)

  • Food & Beverage
  • Dietary Supplements
  • Cosmetics and Personal Care

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions